facit.ca

FACIT | Fight Against Cancer Innovation Trust

Funded Projects and Companies. Cancer Breakthroughs. Realized. We help transform groundbreaking cancer-related research and innovation in Ontario into viable commercial opportunities. We know the business of science. We bridge the funding gap. We are the gateway to Ontario's oncology assets. Turnstone Biologics Announces Enrollment in Landmark Oncolytic Vaccine Trial. Marabex trial to assess the safety of a novel tumour-targeted oncolytic virus vaccine in patients with advanced solid tumours. Roger J Gar...

http://www.facit.ca/

OVERVIEW OF facit.ca

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR FACIT.CA

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

April

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.0 out of 5 with 7 reviews

5 star

2

4 star

0

3 star

3

2 star

0

1 star

2

Hey there! Start your review of facit.ca

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.5 seconds

FAVICON PREVIEW

16x16

CONTACTS AT FACIT.CA

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

18

SSL

EXTERNAL LINKS

12

SITE IP

206.108.121.165

LOAD TIME

0.516 sec

SCORE

6.2

PAGE TITLE

FACIT | Fight Against Cancer Innovation Trust | facit.ca Reviews

<META> DESCRIPTION

Funded Projects and Companies. Cancer Breakthroughs. Realized. We help transform groundbreaking cancer-related research and innovation in Ontario into viable commercial opportunities. We know the business of science. We bridge the funding gap. We are the gateway to Ontario's oncology assets. Turnstone Biologics Announces Enrollment in Landmark Oncolytic Vaccine Trial. Marabex trial to assess the safety of a novel tumour-targeted oncolytic virus vaccine in patients with advanced solid tumours. Roger J Gar...

<META> KEYWORDS

1 menu

2 search form

3 how we work

4 leadership

5 funds

6 catalyst

7 ipdc

8 investment opportunities

9 news

10 latest news

CONTENT

Page content here

KEYWORDS ON PAGE

menu,search form,how we work,leadership,funds,catalyst,ipdc,investment opportunities,news,latest news,see all,facit at a glance,our strategic partner,facit,investee #turnstonebiologics,virus #vaccine,http / t co/syscwpqxiw,stay informed,footer form

SERVER

Apache/2.2.16 (Debian)

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

FACIT | Fight Against Cancer Innovation Trust | facit.ca Reviews

https://facit.ca

Funded Projects and Companies. Cancer Breakthroughs. Realized. We help transform groundbreaking cancer-related research and innovation in Ontario into viable commercial opportunities. We know the business of science. We bridge the funding gap. We are the gateway to Ontario's oncology assets. Turnstone Biologics Announces Enrollment in Landmark Oncolytic Vaccine Trial. Marabex trial to assess the safety of a novel tumour-targeted oncolytic virus vaccine in patients with advanced solid tumours. Roger J Gar...

INTERNAL PAGES

facit.ca

1

FACIT | Fight Against Cancer Innovation Trust

https://facit.ca/funds

Funded Projects and Companies. One of the barriers to the successful commercialization of innovative technology is the scarcity of funding to support early stage applied research and development. FACIT exists to make it possible for the best ideas arising from cancer research in Ontario to become viable commercial opportunities. We provide funding opportunities for various stages of support, including:. Intellectual Property Development and Commercialization (IPDC) Funding. Sidebar - Latest News. MaRS Ce...

2

FACIT | Fight Against Cancer Innovation Trust

https://facit.ca/catalyst-fund

Funded Projects and Companies. Catalyst Fund: Ignite the Spark. FACIT’s Catalyst Fund is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions and start-ups that fit with FACIT’s Investment Strategy and have the potential to act as deal flow for the IPDC Fund. Awarded grants typically range between $50,000 and $200,000. The Catalyst Fund is accepting pre-submission forms twice yearly on the following dates:. The pre-submission form can be downloaded here.

3

FACIT | Fight Against Cancer Innovation Trust

https://facit.ca/news/fluorinov-facit-and-oicr-announce-novel-candidate-drugs-safer-treatment-cancer-pain-and-brain-0

Funded Projects and Companies. Fluorinov, FACIT and OICR announce novel candidate drugs. Fluorinov, FACIT and OICR announce novel candidate drugs. Fluorinov has developed three structurally distinct candidate drugs intended to treat cancer pain and brain cancer-related epilepsy. Fluorinov is currently working with the Fight Against Cancer Innovation Trust (FACIT) to explore partnerships with investors and pharmaceutical companies and also pathways for clinical development. The ion channel development pro...

4

FACIT | Fight Against Cancer Innovation Trust

https://facit.ca/news/xlv-diagnostics-inc-secures-3-million-series-investment

Funded Projects and Companies. XLV Diagnostics Inc. secures a $3 Million Series A investment. XLV Diagnostics Inc. secures a $3 Million Series A investment. XLV Diagnostics Inc. specializes in low-cost, next-generation digital mammography machines. XLV's product will provide mammography image quality equivalent to top-of-the-line mammography machines currently in use, and will do so at a fraction of the cost of current generation systems. Marcovici, named CEO in 2014, brings many years of worldwide, corp...

5

FACIT | Fight Against Cancer Innovation Trust

https://facit.ca/news/luke-m-beshar-appointed-fluorinov-pharma-board-directors

Funded Projects and Companies. Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors. Luke M. Beshar Appointed to Fluorinov Pharma Board of Directors. Fluorinov Pharma and FACIT announce the appointment of Luke M. Beshar, to Fluorinov's Board of Directors. Together with our recent Board appointment of Dr. Roger Garceau, Luke will be a key leader in setting the strategic direction during this period of rapid growth for Fluorinov," said Jim Groninger, Board Director at Fluorinov and former Bo...

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

triphaseco.com

Investors & Founding Organizations | Triphase Accelerator Corporation

http://triphaseco.com/investors

Ontario Institute for Cancer Research (OICR. MaRS Innovation provides an integrated commercialization platform that harnesses the economic potential of the exceptional discovery pipeline of 17 leading Toronto academic institutions. MaRS Innovation is a non-profit organization with an independent Board of Directors, funded through the Government of Canada’s Center of Excellence for Commercialization and Research (CECR) Program and contributions of its member institutions, as well as support from the P...

trac.utoronto.ca

TRAC | News & Events

http://www.trac.utoronto.ca/news.html

Pionyr Immunotherapeutics, co-founded by Dr. Sidhu, closes financing with focus on developing antibody-based immuno-oncology therapeutics - January 2017. Pionyr Immunotherapeutics Inc. (formerly Precision Immune Inc.), a company co-founded in 2015 by Dr. Sidhu and UCSF Professor Max Krummel. To harness the body’s antitumor immunity by fine-tuning the tumor microenvironment, announced the closing of an $8 million Series A-1 investment round. Said Steven James, Pionyr’s executive chairman and interim CEO&#...

fusionpharma.com

Press – Fusion Pharmaceuticals

http://fusionpharma.com/category/press

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments. February 23, 2017. HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing led by founding venture investor, Johnson and Johnson Innovation. JJDC, Inc., with investments by HealthCap. Centyrins are...

fusionpharma.com

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics – Fusion Pharmaceuticals

http://fusionpharma.com/facit-announces-investment-in-fusion-pharmaceuticals-and-alpha-emitting-radiotherapeutics

FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics. January 9, 2016. Image-guided medicines for hard to treat cancers built using next generation medical isotopes. Or email info@facit.ca. Fusion Pharmaceuticals is a clinical stage company focused on developing novel radiotherapeutics for the treatment of cancer. Fusion is a spin-out from the Centre for Probe Development and Commercialization (CPDC). 1280 Main St. West. 905) 525-9140 Ext. 21212.

fusionpharma.com

Press – Fusion Pharmaceuticals

http://fusionpharma.com/press

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments. February 23, 2017. HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing led by founding venture investor, Johnson and Johnson Innovation. JJDC, Inc., with investments by HealthCap. Centyrins are...

fusionpharma.com

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments – Fusion Pharmaceuticals

http://fusionpharma.com/fusion-pharmaceuticals-launches-with-a-25m-usd-series-a-financing-to-develop-targeted-radiotherapeutics-as-cancer-treatments

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments. February 23, 2017. HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced the closing of a $25 million Series A financing led by founding venture investor, Johnson and Johnson Innovation. JJDC, Inc., with investments by HealthCap. Centyrins are...

spellingbee.ca

Spellingbee Communications Inc.

http://www.spellingbee.ca/clients

Communication is the cornerstone of every good relationship. We’re quite proud of the relationships we’ve built over the years. Clear Space Design and Communications. Craib Design and Communications. Association of Registered Graphic Designers. Christian Children’s Fund of Canada. Healthcare of Ontario Pension Plan. JDRF Canada: Revolution Ride. My Dog Spot Pet Grooming. Osler, Hoskin and Harcourt LLP. TFS Canada’s International School. Toronto Community Housing Report. Unisource Canada: CMYK Awards.

oicr-iorc.ca

About | OICR Bilingual

http://www.oicr-iorc.ca/en/about.html

Ontario Institute for Cancer Research. The Ontario Institute for Cancer Research (OICR) is an innovative translational research organization dedicated to research on the prevention, early detection, diagnosis and treatment of cancer. OICR was launched by the Government of Ontario in December 2005. To tackle the big questions in cancer research. Translation of research findings into:. Activities strategically chosen to focus on areas of the highest potential impact on patients;. Cancer Care Ontario;.

spellingbee.ca

Spellingbee Communications Inc.

http://www.spellingbee.ca/projects

We provide integrated copywriting and creative services to designers, agencies and directly to businesses both large and small. Our breadth of experience encompasses marketing communications, advertising, naming, brand development and the art of winning hearts and minds. Antonacci Suits Brand Story. Branksome Hall Capital Campaign. Build Toronto Annual Reports. Healthcare of Ontario Pension Plan. JDRF Canada Ride for Diabetes Research. Osler, Hoskin and Harcourt LLP. Red Box Brand Story. Superior perform...

UPGRADE TO PREMIUM TO VIEW 3 MORE

TOTAL LINKS TO THIS WEBSITE

12

SOCIAL ENGAGEMENT

sharer/sharer.php

facitca

OTHER SITES

facit-testing.co.uk

Facit Testing

Electrical Portable Appliance Testing and Fixed Installation. Testing services throughout England and Wales. With over 30 years experience, Facit Testing provides electrical Portable Appliance Testing. And Fixed Installation Testing. Tried and tested for quality. It is no coincidence that we've been providing electrical safety testing, electrical installation, and electrical services to the UK market for over 30 years. Our aim has always been to provide a proactive, long-term service solution that is...

facit-uk.com

北京赛车pk10 PK10开奖直播北京赛车pk10开奖结果历史记录 - pk直播网

在一项新的研究中，瑞士巴塞尔大学生物中心的Michael N. Hall教授及其团队发现一种新的抗癌蛋白。学术微信靶向治疗与精准医学账号 zlbxzl. 中企动力提供网站建设企业邮箱 OA系统信息管理系统.

facit.ba

Naslovnica

Facit d.o.o. PJ Facit - Mostar. Servis i tehnička podrška. Servisiranje i održavanje opreme. FACIT Biblioteka v2.0. FACIT Biblioteka v3.0. Facit doo - Direkcija. Proizvodi na akcijskoj ponudi! Klikni za odličnu ponudu! SERVIS I TEHNIČKA PODRŠKA. Helpdesk 033 229 332. Printanje, uvezivanje, plotanje. Nemate sredstava za nabavu novog kopira? Kliknite i iznajmite Vaš kopir uređaj! Xerox predstavlja novu seriju višefunkcijskih pisača za mala i srednja poduzeća. Serija se odlikuje brzinama ispisa od 25 ppm do...

facit.be

abercrombie en fitch En Verkoop abercrombie fitch nederland Overhemd Casual

Nieuw in ons assortiment [lees meer]. Onderscheidend Abercrombi Fitch Vrouwen Hoodies Y6525 Store Nijmegen. Kopen Groningen Abercrombi Fitch Vrouwen Hoodies Rf1129 Hoge Quaity. Officieel Abercrombi Fitch Vrouwen Hoodies enS3108 Outlet Sale. Cutting Edge Abercrombi Fitch vrouwen Tees SD1758 Online. Uniek Ontwerp Abercrombi Fitch Heren Tees GaG658 Van Bekende Merken. Abercrombie and fitch belgium. Nieuwe artikelen voor augustus. Modern Abercrombi Fitch Heren Overhemd Edi2767 Wholesale Store.

facit.biz

Bluehost.com

2003-2018 Bluehost.Com. Toll Free (888) 401-HOST(4678).

facit.ca

FACIT | Fight Against Cancer Innovation Trust

Funded Projects and Companies. Cancer Breakthroughs. Realized. We help transform groundbreaking cancer-related research and innovation in Ontario into viable commercial opportunities. We know the business of science. We bridge the funding gap. We are the gateway to Ontario's oncology assets. Turnstone Biologics Announces Enrollment in Landmark Oncolytic Vaccine Trial. Marabex trial to assess the safety of a novel tumour-targeted oncolytic virus vaccine in patients with advanced solid tumours. Roger J Gar...

facit.carprofessional.de

Car Professional Management

Für Sie und Ihren Fuhrpark. Wir freuen uns über Ihr Interesse an Car Professional Management, eines der marktführenden Fuhrparkmanagement-Unternehmen in Deutschland. Car Professional Management ist ein herstellerunabhängiges Unternehmen mit Hauptsitz in Hamburg, das sich auf das Management großer Fahrzeugflotten spezialisiert hat und einen steilen Erfolgskurs eingeschlagen hat. Car Professional Management: Part of ALD Automotive - Societe Generale Group. CPM-Notfall-Hotline: 0800 802 63 48.

facit.ch

web304 @ mis63.de

Hier entstehen die Internet-Seiten des Parallels Confixx Benutzers. This page is autogenerated by Parallels.

facit.co.jp

ファシット株式会社

Took over all sales and service activities of Facit products. TEL: 03-5652-1715 アドージャパン株式会社の電話番号です. TEL: 81 (3) 5652-1715 (Phone number of ADDO-Japan Corp.).

facit.co.uk

facit.co.uk - This website is for sale! - facit Resources and Information.

Find the best information and most relevant links on all topics related to facit.co.uk.

facit.com

Förenklar nybilsköpet

För att ge dig en bättre upplevelse på våra webbplatser använder vi cookies på din enhet och sparar ditt IP-nummer. Genom att fortsätta använda vår webbplats accepterar du att cookies används. Om du inte godkänner eller vill ha mer information kan du läsa mer här. Senaste biltester på FACIT.com. Vi rockar loss med Volkswagen T-Roc. Nya Dacia Duster - en förbättrad och prisvärd SUV. Nya Volkswagen POLO - säkraste bilen i segmentet. KIA Optima Sportswagon Plug-in Hybrid - räckvidd som håller! Vi har testat...